CA1162188A - Intra-or intermolecular disulfide of cysteine derivatives - Google Patents
Intra-or intermolecular disulfide of cysteine derivativesInfo
- Publication number
- CA1162188A CA1162188A CA000386241A CA386241A CA1162188A CA 1162188 A CA1162188 A CA 1162188A CA 000386241 A CA000386241 A CA 000386241A CA 386241 A CA386241 A CA 386241A CA 1162188 A CA1162188 A CA 1162188A
- Authority
- CA
- Canada
- Prior art keywords
- formula
- methyl
- preparing
- compound
- iii
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 title claims abstract description 9
- 150000001944 cysteine derivatives Chemical class 0.000 title abstract description 4
- 150000001875 compounds Chemical class 0.000 claims abstract description 24
- 150000003839 salts Chemical class 0.000 claims abstract description 9
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 4
- 125000002947 alkylene group Chemical group 0.000 claims abstract description 3
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims abstract 4
- 238000004519 manufacturing process Methods 0.000 claims description 11
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 8
- 229910052757 nitrogen Inorganic materials 0.000 claims description 6
- 239000004158 L-cystine Substances 0.000 claims description 5
- 229960003067 cystine Drugs 0.000 claims description 5
- IDIDJDIHTAOVLG-UHFFFAOYSA-N S-methyl-L-cysteine Natural products CSCC(N)C(O)=O IDIDJDIHTAOVLG-UHFFFAOYSA-N 0.000 claims description 4
- IDIDJDIHTAOVLG-VKHMYHEASA-N S-methylcysteine Chemical compound CSC[C@H](N)C(O)=O IDIDJDIHTAOVLG-VKHMYHEASA-N 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 4
- AXMCBAWKHOPUEZ-BYPYZUCNSA-N (4r)-7,7-dimethyl-6-oxo-1,2,5-dithiazepane-4-carboxylic acid Chemical compound CC1(C)SSC[C@@H](C(O)=O)NC1=O AXMCBAWKHOPUEZ-BYPYZUCNSA-N 0.000 claims description 3
- -1 2-methyl-propanoyl Chemical group 0.000 claims description 3
- 238000006243 chemical reaction Methods 0.000 claims description 3
- SDNJNDFHCODQDQ-UHFFFAOYSA-N n-(2-ethylphenyl)-2-[[2-[(2-ethylphenyl)carbamoyl]phenyl]disulfanyl]benzamide Chemical compound CCC1=CC=CC=C1NC(=O)C1=CC=CC=C1SSC1=CC=CC=C1C(=O)NC1=CC=CC=C1CC SDNJNDFHCODQDQ-UHFFFAOYSA-N 0.000 claims description 3
- 239000007800 oxidant agent Substances 0.000 claims description 3
- 230000003647 oxidation Effects 0.000 claims description 3
- 238000007254 oxidation reaction Methods 0.000 claims description 3
- 125000001325 propanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 claims description 3
- BTQOZOZMULUOMU-UHFFFAOYSA-N 2-methyl-2-methylsulfanylpropanoyl chloride Chemical compound CSC(C)(C)C(Cl)=O BTQOZOZMULUOMU-UHFFFAOYSA-N 0.000 claims description 2
- VUAFHZCUKUDDBC-BYPYZUCNSA-N Bucillamine Chemical compound CC(C)(S)C(=O)N[C@@H](CS)C(O)=O VUAFHZCUKUDDBC-BYPYZUCNSA-N 0.000 claims description 2
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 claims description 2
- 235000019393 L-cystine Nutrition 0.000 claims description 2
- 230000005587 bubbling Effects 0.000 claims description 2
- JZCCFEFSEZPSOG-UHFFFAOYSA-L copper(II) sulfate pentahydrate Chemical compound O.O.O.O.O.[Cu+2].[O-]S([O-])(=O)=O JZCCFEFSEZPSOG-UHFFFAOYSA-L 0.000 claims description 2
- 230000001590 oxidative effect Effects 0.000 claims 3
- PMUJIERHCGLMCW-UHFFFAOYSA-N 2-[(1-chloro-2-methyl-1-oxopropan-2-yl)disulfanyl]-2-methylpropanoyl chloride Chemical compound ClC(=O)C(C)(C)SSC(C)(C)C(Cl)=O PMUJIERHCGLMCW-UHFFFAOYSA-N 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 3
- 208000002177 Cataract Diseases 0.000 abstract description 2
- 206010067125 Liver injury Diseases 0.000 abstract description 2
- 208000025747 Rheumatic disease Diseases 0.000 abstract description 2
- 201000010099 disease Diseases 0.000 abstract description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 2
- 231100000234 hepatic damage Toxicity 0.000 abstract description 2
- 230000008818 liver damage Effects 0.000 abstract description 2
- 230000001404 mediated effect Effects 0.000 abstract description 2
- 229940124597 therapeutic agent Drugs 0.000 abstract description 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 238000000921 elemental analysis Methods 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 101150041968 CDC13 gene Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical class OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 238000000262 chemical ionisation mass spectrometry Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 125000001664 diethylamino group Chemical class [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000002019 disulfides Chemical class 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000004092 methylthiomethyl group Chemical group [H]C([H])([H])SC([H])([H])* 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 125000004055 thiomethyl group Chemical group [H]SC([H])([H])* 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
- C07C319/20—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides by reactions not involving the formation of sulfide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/02—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of thiols
- C07C319/12—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of thiols by reactions not involving the formation of mercapto groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C321/00—Thiols, sulfides, hydropolysulfides or polysulfides
- C07C321/12—Sulfides, hydropolysulfides, or polysulfides having thio groups bound to acyclic carbon atoms
- C07C321/14—Sulfides, hydropolysulfides, or polysulfides having thio groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/36—Seven-membered rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP131349/1980 | 1980-09-20 | ||
| JP55131349A JPS5756454A (en) | 1980-09-20 | 1980-09-20 | Disulfide type cysteine derivative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1162188A true CA1162188A (en) | 1984-02-14 |
Family
ID=15055849
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000386241A Expired CA1162188A (en) | 1980-09-20 | 1981-09-18 | Intra-or intermolecular disulfide of cysteine derivatives |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US4517123A (en, 2012) |
| JP (1) | JPS5756454A (en, 2012) |
| KR (1) | KR880000041B1 (en, 2012) |
| AU (1) | AU7590081A (en, 2012) |
| BE (1) | BE890399A (en, 2012) |
| CA (1) | CA1162188A (en, 2012) |
| DE (1) | DE3152362C2 (en, 2012) |
| ES (1) | ES505628A0 (en, 2012) |
| FR (1) | FR2490637A1 (en, 2012) |
| GB (1) | GB2096145B (en, 2012) |
| IT (1) | IT1138226B (en, 2012) |
| SE (1) | SE447379B (en, 2012) |
| WO (1) | WO1982001000A1 (en, 2012) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0326326B1 (en) * | 1988-01-25 | 1993-01-07 | Santen Pharmaceutical Co., Ltd. | Cysteine derivatives |
| US5041435A (en) * | 1988-08-13 | 1991-08-20 | Santen Pharmaceutical Co., Ltd. | Cyclic sulfur-containing compounds |
| US5081307A (en) * | 1989-07-14 | 1992-01-14 | Kawaguchi Chemical Co., Ltd. | Process for preparing 2,2-dimethoxy-2-phenylacetophenone |
| JP2720217B2 (ja) * | 1989-12-05 | 1998-03-04 | 参天製薬株式会社 | 含硫黄アミノ酸誘導体 |
| US5175256A (en) * | 1990-09-28 | 1992-12-29 | Neorx Corporation | Protein labeling reagents |
| JP2843955B2 (ja) * | 1992-08-01 | 1999-01-06 | 参天製薬株式会社 | 抗白内障剤 |
| US5670545A (en) * | 1996-02-09 | 1997-09-23 | Board Of Regents Of The University Of Colorado | Method for the treatment of ischemic disease and reperfusion injury and the prevention of the adverse effects of reactive oxygen species |
| US10655227B2 (en) | 2017-10-06 | 2020-05-19 | Rohm And Haas Electronic Materials Llc | Stable electroless copper plating compositions and methods for electroless plating copper on substrates |
| US10294569B2 (en) | 2017-10-06 | 2019-05-21 | Rohm And Haas Electronic Materials Llc | Stable electroless copper plating compositions and methods for electroless plating copper on substrates |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5271928A (en) * | 1975-12-11 | 1977-06-15 | Sony Corp | Receiving and recording unit of tv signals |
| JPS535112A (en) * | 1976-03-08 | 1978-01-18 | Santen Pharmaceutical Co Ltd | New cysteine derivatives |
| JPS545916A (en) * | 1977-06-17 | 1979-01-17 | Santen Pharmaceutical Co Ltd | Novel cystein derivative |
| JPS6058908B2 (ja) * | 1978-10-11 | 1985-12-23 | 参天製薬株式会社 | システイン誘導体 |
| JPS6011888B2 (ja) * | 1978-10-11 | 1985-03-28 | 参天製薬株式会社 | リウマチ疾患治療薬 |
-
1980
- 1980-09-20 JP JP55131349A patent/JPS5756454A/ja active Granted
-
1981
- 1981-09-18 US US06/380,665 patent/US4517123A/en not_active Expired - Lifetime
- 1981-09-18 AU AU75900/81A patent/AU7590081A/en not_active Abandoned
- 1981-09-18 GB GB8214992A patent/GB2096145B/en not_active Expired
- 1981-09-18 WO PCT/JP1981/000235 patent/WO1982001000A1/ja active Application Filing
- 1981-09-18 CA CA000386241A patent/CA1162188A/en not_active Expired
- 1981-09-18 DE DE19813152362 patent/DE3152362C2/de not_active Expired
- 1981-09-18 BE BE2/59362A patent/BE890399A/fr not_active IP Right Cessation
- 1981-09-18 ES ES505628A patent/ES505628A0/es active Granted
- 1981-09-19 KR KR1019810003505A patent/KR880000041B1/ko not_active Expired
- 1981-09-21 IT IT24057/81A patent/IT1138226B/it active
- 1981-09-21 FR FR8117808A patent/FR2490637A1/fr active Granted
-
1982
- 1982-05-14 SE SE8203053A patent/SE447379B/sv not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US4517123A (en) | 1985-05-14 |
| GB2096145B (en) | 1984-05-02 |
| JPS6143350B2 (en, 2012) | 1986-09-26 |
| IT8124057A0 (it) | 1981-09-21 |
| GB2096145A (en) | 1982-10-13 |
| BE890399A (fr) | 1982-01-18 |
| DE3152362C2 (de) | 1986-08-28 |
| AU7590081A (en) | 1982-04-14 |
| IT1138226B (it) | 1986-09-17 |
| KR880000041B1 (ko) | 1988-02-20 |
| SE8203053L (sv) | 1982-05-14 |
| ES8303316A1 (es) | 1983-02-01 |
| FR2490637A1 (fr) | 1982-03-26 |
| WO1982001000A1 (en) | 1982-04-01 |
| SE447379B (sv) | 1986-11-10 |
| DE3152362T1 (en, 2012) | 1982-10-07 |
| JPS5756454A (en) | 1982-04-05 |
| KR830007539A (ko) | 1983-10-21 |
| ES505628A0 (es) | 1983-02-01 |
| FR2490637B1 (en, 2012) | 1984-12-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100265181B1 (ko) | 디설파이드 그룹을 함유하는 니트레이트 | |
| US5442110A (en) | Hydroxamic acid derivative | |
| EP0348203B1 (en) | Phenolic thioethers, their production and use | |
| EP0536231B1 (en) | A process for the preparation of glutathione s-acyl derivatives and compounds obtained from said process | |
| CA1162188A (en) | Intra-or intermolecular disulfide of cysteine derivatives | |
| US4305958A (en) | Cysteine derivatives | |
| KR970002904B1 (ko) | S-저급지방산 글루타티온 유도체 | |
| US4210754A (en) | Morpholino containing benzamides | |
| ES2523653T3 (es) | Procedimiento para sintetizar sales de disulfuro farmacéuticamente activas | |
| US5350767A (en) | Derivatives of cysteine | |
| ZA807176B (en) | Alkenyl-substituted thienylalkanecarboxylic acids and derivatives thereof, methods for preparation of these compounds, and pharmaceutical compositions thereof | |
| NZ238495A (en) | N-acyl derivatives of cystine and esters thereof; and pharmaceutical compositions | |
| GB2032433A (en) | Cysteine derivatives | |
| EP0317540B1 (en) | Cysteine derivatives, processes for their preparation and their use | |
| RU2034834C1 (ru) | (4-амино-2,6-диметилфенилсульфонил)нитрометан, (4-ацетамидо-2,6-диметилфенилсульфонил)нитрометан и фармацевтическая композиция, обладающая свойствами ингибитора фермента альдозоредуктазы | |
| EP0301474B1 (en) | New cysteine derivatives having expectorant activity | |
| GB2123815A (en) | Aletheine derivatives | |
| US5872281A (en) | Amino acid derivative having N,N-dialkylaminophenyl group | |
| CA1076112A (en) | Benzamides | |
| US20060063949A1 (en) | Medicinal disulfide salts | |
| US4226865A (en) | Method of treating depression | |
| ES8403124A1 (es) | "procedimiento para preparar esteres del acido vincaminico racemicos y opticamente activos". | |
| CA1118419A (en) | Hexahydro-1-mercaptoacyl-1h-azepine-2- carboxylic acids and esters | |
| US4464371A (en) | Five-membered heterocyclic compounds | |
| JPH04173775A (ja) | アニリド誘導体 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |